- Home
- SRZN vs ENZ Comparison
SRZN vs ENZ Comparison
Compare SRZN & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- ENZ
- Stock Information
- Founded
- SRZN 2015
- ENZ 1976
- Country
- SRZN United States
- ENZ United States
- Employees
- SRZN N/A
- ENZ N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- ENZ Medical Specialities
- Sector
- SRZN Health Care
- ENZ Health Care
- Exchange
- SRZN Nasdaq
- ENZ Nasdaq
- Market Cap
- SRZN 38.1M
- ENZ 34.2M
- IPO Year
- SRZN N/A
- ENZ N/A
- Fundamental
- Price
- SRZN $11.70
- ENZ $0.66
- Analyst Decision
- SRZN Strong Buy
- ENZ
- Analyst Count
- SRZN 1
- ENZ 0
- Target Price
- SRZN $45.00
- ENZ N/A
- AVG Volume (30 Days)
- SRZN 51.3K
- ENZ 132.8K
- Earning Date
- SRZN 11-06-2024
- ENZ 03-12-2025
- Dividend Yield
- SRZN N/A
- ENZ N/A
- EPS Growth
- SRZN N/A
- ENZ N/A
- EPS
- SRZN N/A
- ENZ N/A
- Revenue
- SRZN $10,000,000.00
- ENZ $30,314,000.00
- Revenue This Year
- SRZN N/A
- ENZ N/A
- Revenue Next Year
- SRZN N/A
- ENZ N/A
- P/E Ratio
- SRZN N/A
- ENZ N/A
- Revenue Growth
- SRZN N/A
- ENZ N/A
- 52 Week Low
- SRZN $6.00
- ENZ $0.63
- 52 Week High
- SRZN $18.17
- ENZ $1.40
- Technical
- Relative Strength Index (RSI)
- SRZN 48.38
- ENZ 33.26
- Support Level
- SRZN $10.20
- ENZ $0.63
- Resistance Level
- SRZN $13.28
- ENZ $0.72
- Average True Range (ATR)
- SRZN 1.98
- ENZ 0.04
- MACD
- SRZN -0.23
- ENZ 0.01
- Stochastic Oscillator
- SRZN 20.22
- ENZ 20.77
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.